Muscarinic M3 antagonists (Nuada)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameMuscarinic M3 antagonists (Nuada)
Drug Alias NameProject C (Nuada)FF2 project (Nuada)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor M3 antagonists
TargetsMuscarinic acetylcholine receptor M3
Therapy Area/IndicationsUrinary IncontinencePulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNuada Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNuada Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsUrinary IncontinencePulmonary Disease, Chronic Obstructive

Other Information

ATC CodeN/A
Related LinksN/A